Alendronate in Cats

Alendronate is an oral bisphosphonate that your vet may prescribe for cats with high blood calcium, especially idiopathic hypercalcemia. In cats, this is an extra-label medication, which means it is not specifically FDA-approved for feline use but is used in veterinary medicine based on clinical experience and published studies. VCA notes that it is used to treat high calcium levels in cats and dogs, and veterinary literature describes its use for persistent ionized hypercalcemia in cats.

Most cats receiving alendronate are being treated for a calcium problem rather than a bone disease. Hypercalcemia can happen for several reasons, including kidney disease, cancer, primary hyperparathyroidism, vitamin D toxicity, dehydration, or idiopathic hypercalcemia. Because the medication treats the calcium imbalance rather than the root cause, your vet usually recommends a diagnostic workup before or during treatment.

This medication is not a do-it-yourself option. It can irritate the mouth, throat, and esophagus if given incorrectly, and it may not be appropriate for cats with severe kidney disease or swallowing problems. Your vet may also pair it with diet changes, hydration support, or treatment for the underlying condition, depending on what is driving the calcium elevation.

Alendronate slows the activity of osteoclasts, the cells that break down bone. When bone is resorbed, calcium is released into the bloodstream. By reducing that process, alendronate can help lower blood calcium over time. This is why it is grouped with bisphosphonates, a class of drugs used to reduce bone resorption.

In cats with idiopathic hypercalcemia, the goal is often to bring ionized calcium down into a safer range and reduce the risk of ongoing complications. High calcium can affect the kidneys, urinary tract, muscles, heart, and gastrointestinal tract. Some cats also form calcium oxalate stones, so controlling calcium may be one part of a broader management plan.

Alendronate does not work instantly. VCA notes that it may begin taking effect within a few days, but the clinical benefit is often judged by follow-up lab work rather than what a pet parent sees at home. Published feline studies suggest many cats tolerate weekly treatment well, but response varies, so your vet may adjust the plan based on repeat ionized calcium, phosphorus, kidney values, symptoms, and diet response.

The most commonly reported side effects are gastrointestinal. VCA lists vomiting and decreased appetite as expected possibilities. Mouth or throat irritation, drooling, and ulceration are more concerning because this medication can be irritating to tissues if it lingers in the mouth or esophagus. That is one reason your vet may give very specific instructions about how to administer it.

Rare but important risks include allergic reactions and problems related to over-suppression of calcium or mineral balance. In published feline studies, alendronate was generally well tolerated, but complications such as hypophosphatemia have been reported. More recent case reports and retrospective work also raise concern for medication-related osteonecrosis of the jaw in some cats receiving bisphosphonates, especially with long-term use or concurrent dental disease.

See your vet immediately if your cat has repeated vomiting, refuses food, drools excessively, paws at the mouth, seems painful when swallowing, develops facial swelling, or shows sudden lethargy or weakness. If your cat already has dental disease, oral pain, kidney disease, or trouble swallowing, tell your vet before starting treatment so the plan can be tailored more safely.

Alendronate dosing in cats is individualized by your vet. Published feline references commonly describe a starting dose around 5 to 10 mg per cat by mouth once weekly for idiopathic hypercalcemia, with many cats starting at 10 mg per cat weekly and some needing dose adjustments based on follow-up calcium levels. Because this is extra-label use, the exact schedule, formulation, and monitoring plan can vary.

Administration matters as much as the dose. VCA advises giving alendronate by mouth on an empty stomach and waiting at least 30 minutes before offering food. Small amounts of water after the dose are considered acceptable. Many vets prefer careful pill followed by water technique or a compounded liquid when administration is difficult, because prolonged contact with the mouth or esophagus can increase irritation risk.

Do not crush, split, or reformulate the medication unless your vet or pharmacist specifically instructs you to do so. If you miss a dose, contact your vet or follow the label directions rather than doubling up. Cats on alendronate usually need recheck bloodwork, especially ionized calcium, phosphorus, and kidney values, to make sure the plan is helping and remains safe.

Alendronate can interact with several products that reduce absorption or increase side effect risk. VCA specifically advises caution with aspirin, aminoglycosides, and oral products containing calcium, magnesium, or aluminum. In practical terms, that means antacids, mineral supplements, and some binders or compounded products may need to be timed separately or avoided.

Your vet will also consider the full medical picture. Cats with kidney disease, dehydration, swallowing disorders, active oral disease, or a history of esophageal problems may need a different plan. If your cat is taking steroids, diuretics, phosphate binders, pain medications, or supplements, bring a full list to the appointment, including over-the-counter products and treats.

Because alendronate is often used in cats with hypercalcemia, it is common for treatment to involve more than one step. Diet change, hydration support, stone prevention, and treatment of an underlying disease may all matter. The safest approach is to let your vet coordinate the whole plan rather than adding or stopping medications at home.